Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

Front Pharmacol. 2023 Jul 26:14:1243304. doi: 10.3389/fphar.2023.1243304. eCollection 2023.

Authors

Affiliations

¹ Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
² Institute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, China.
³ State Key Laboratory of Generic Manufacture Technology of Chinese Traditional Medicine, Linyi, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.875700.].

Keywords: 16S sequencing; high-fat diet; intestinal flora disorder; network pharmacology; nonalcoholic simple fatty liver.

Copyright © 2023 Liu, Tan, Huang, Wu, Fan, Stalin, Lu, Wang, Zhang, Zhang, Wu, Li, Huang, Chen, Cheng, Mou and Wu.

Publication types

Published Erratum